デフォルト表紙
市場調査レポート
商品コード
1518280

うっ血性心不全治療デバイスの世界市場レポート 2024年

Congestive Heart Failure Treatment Devices Global Market Report 2024


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.91円
うっ血性心不全治療デバイスの世界市場レポート 2024年
出版日: 2024年07月22日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

うっ血性心不全治療デバイスの市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.9%で265億7,000万米ドルに成長します。予測期間の拡大は、高齢者の割合の増加、心臓の健康に関する意識の高まり、スクリーニングイニシアチブの開始、構造的心臓介入に対する有利な償還制度、新規の構造的心臓デバイスに対する迅速な規制クリアランスなど、いくつかの要因によるものです。この期間に予想される重要な動向には、経カテーテル弁置換術の普及、デバイス材料の継続的な技術革新、オーダーメイド治療戦略への注目の高まり、ハイブリッド手術アプローチの採用増加、遠隔モニタリングと遠隔医療ソリューションの統合などが含まれます。

心血管疾患の罹患率の増加は、当面のうっ血性心不全治療デバイス市場の拡大を牽引すると予想されます。心血管疾患には、冠動脈疾患、高血圧、心不全を含む心臓や血管の病気が含まれ、血液循環や心臓全体の健康に影響を与えます。このような心血管障害の有病率の急増は、主に肥満、座りがちなライフスタイル、食生活の乱れ、高齢化などの危険因子の割合が増加していることに起因しています。うっ血性心不全治療デバイスは、心臓のリズムを調整し、心機能を強化することによって、心血管疾患の管理に重要な役割を果たし、患者の予後を著しく改善します。例えば、国家統計局が2022年3月に報告したように、心臓発作に起因する死亡者数は、2020年の19,440人から2021年には20,061人に増加しました。したがって、心血管障害の有病率の上昇は、うっ血性心不全(CHF)治療機器市場の成長を促進します。

うっ血性心不全治療デバイス市場の主要プレーヤーは、競争上の優位性を獲得するために、Bluetooth対応ペースメーカーなどの最先端製品を導入して技術革新を進めています。ブルートゥース接続を搭載したこれらのペースメーカーは、心臓のリズムを調整するだけでなく、データをヘルスケアプロバイダーにワイヤレスで送信し、遠隔モニタリングや調整を行うことができます。例えば、2021年6月、フランスの医療機器会社Microport Crm S.R.L.は、ブルートゥース接続と合理化された遠隔モニタリングを特徴とするペースメーカーAlizeaとBoreaを発売しました。この技術により、循環器専門医はこれらの機器を遠隔監視できるようになり、患者が定期検診のために病院を訪れる必要性が減る。SmartView Connectホームモニターは、詳細な性能レポートを提供することで、この遠隔モニタリングを補完します。AlizeaおよびBoreaペースメーカーは、13年の寿命が見込まれ、コンパクトで、SafeRモードやリアルタイムEGMなどの高度な機能を備えています。これらの技術革新は、病院への通院を最小限に抑え、継続的なモニタリングとフォローアップを確実にすることで、ヘルスケア管理を改善することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のうっ血性心不全治療デバイス市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のうっ血性心不全治療デバイス市場の実績:規模と成長, 2018-2023
  • 世界のうっ血性心不全治療デバイス市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界のうっ血性心不全治療デバイス市場:製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 心臓ペースメーカー
  • 植込み型除細動器(ICD)
  • 心臓再同期療法装置(CRT)
  • カウンターパルセーション装置
  • 心室補助装置(VAD)
  • 世界のうっ血性心不全治療デバイス市場:用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 左心室補助装置(LVAD)
  • 右心室補助装置(RVAD)
  • 両心室補助装置(BIVAD)
  • 世界のうっ血性心不全治療デバイス市場:エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院とクリニック
  • 心臓血管疾患専門治療センター
  • 外来手術センター

第7章 地域別・国別分析

  • 世界のうっ血性心不全治療デバイス市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のうっ血性心不全治療デバイス市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • うっ血性心不全治療デバイス市場:競合情勢
  • うっ血性心不全治療デバイス市場:企業プロファイル
    • Abbott Laboratories
    • Medtronic plc
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Terumo Corporation

第31章 その他の大手企業と革新的企業

  • Edwards Lifesciences Corporation
  • Charles River Laboratories International Inc.
  • W. L. Gore & Associates Inc.
  • Bracco Group
  • LivaNova PLC
  • Meril Life Sciences Pvt. Ltd.
  • Biotronik SE & Co. KG
  • CryoLife Inc.
  • HeartWare International Inc.
  • Direct Flow Medical Inc.
  • Berlin Heart GmbH
  • CVRx Inc.
  • Micro Interventional Devices Inc.
  • Jarvik Heart Inc
  • CardioKinetix Inc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18325

A congestive heart failure (CHF) treatment device is a medical tool created to assist in managing and addressing the effects of this condition, wherein the heart struggles to efficiently pump blood, resulting in fluid accumulation in the lungs and other tissues. Such devices play a role in monitoring, supporting, or enhancing heart function, thereby mitigating symptoms and reducing the likelihood of complications and hospitalizations associated with congestive heart failure.

The primary types of devices used in treating congestive heart failure encompass cardiac pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, counter-pulsation devices, and ventricular assist devices (VADs). A cardiac pacemaker, for example, is a small implant placed in the chest to regulate irregular heart rhythms by delivering electrical impulses to restore a normal heartbeat. These devices, including left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs), find utility across various settings, including hospitals, specialized cardiovascular treatment centers, and ambulatory surgery centers.

The congestive heart failure treatment devices market research report is one of a series of new reports from The Business Research Company that provides congestive heart failure treatment devices market statistics, including congestive heart failure treatment devices industry global market size, regional shares, competitors with a congestive heart failure treatment devices market share, detailed congestive heart failure treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the congestive heart failure treatment devices industry. This congestive heart failure treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congestive heart failure treatment devices market size has grown strongly in recent years. It will grow from $18.22 billion in 2023 to $19.61 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to the demand for minimally invasive structural heart devices, the shift towards less invasive surgical techniques, ongoing training and education programs for healthcare professionals, growing patient preference for non-surgical or minimally invasive treatment options and rising healthcare expenditure.

The congestive heart failure treatment devices market size is expected to see strong growth in the next few years. It will grow to $26.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The projected expansion in the forecast period can be credited to several factors, including the rising proportion of elderly individuals, heightened awareness regarding cardiac health, the initiation of screening initiatives, advantageous reimbursement schemes for structural heart interventions, and prompt regulatory clearances for novel structural heart devices. Significant trends anticipated during this period encompass the heightened uptake of transcatheter valve replacement techniques, ongoing innovations in device materials, a growing focus on tailored treatment strategies, increased adoption of hybrid surgical approaches, and the integration of remote monitoring and telemedicine solutions.

The increase in the incidence of cardiovascular conditions is anticipated to drive the expansion of the congestive heart failure treatment devices market in the foreseeable future. Cardiovascular disorders encompass a spectrum of heart and blood vessel ailments, including coronary artery disease, hypertension, and heart failure, affecting blood circulation and overall cardiac health. This surge in cardiovascular disorder prevalence primarily stems from escalating rates of risk factors such as obesity, sedentary lifestyles, poor dietary habits, and aging demographics. Congestive heart failure treatment devices play a vital role in managing cardiovascular conditions by regulating heart rhythms and enhancing cardiac function, significantly improving patient outcomes. For instance, as reported by the Office for National Statistics in March 2022, the number of deaths attributed to heart attacks rose to 20,061 in 2021 from 19,440 in 2020. Hence, the uptick in cardiovascular disorder prevalence propels the growth of the congestive heart failure (CHF) treatment devices market.

Major players in the congestive heart failure treatment devices market are innovating by introducing cutting-edge products, such as Bluetooth-enabled pacemakers, to gain a competitive advantage. These pacemakers, equipped with Bluetooth connectivity, not only regulate heart rhythms but also wirelessly transmit data to healthcare providers for remote monitoring and adjustments. For example, in June 2021, Microport Crm S.R.L., a French medical device company, launched Alizea and Borea pacemakers featuring Bluetooth connectivity and streamlined remote monitoring. This technology allows cardiologists to remotely monitor these devices, reducing the need for patients to visit hospitals for routine check-ups. The SmartView Connect home monitor complements this remote monitoring by providing detailed performance reports. Alizea and Borea pacemakers, with a projected lifespan of 13 years, are compact and come with advanced features such as SafeR mode and real-time EGM. These innovations aim to improve healthcare management by minimizing hospital visits and ensuring continuous monitoring and follow-up.

In December 2022, Johnson & Johnson Services Inc., a pharmaceutical and medical technology company based in the United States, completed the acquisition of Abiomed Inc. for $16.6 billion. Through this strategic move, Johnson & Johnson aims to broaden its presence in the rapidly expanding cardiovascular device market, especially in the segments related to heart failure and recovery solutions. Abiomed Inc., headquartered in the United States, specializes in manufacturing devices for the treatment of congestive heart failure.

Major companies operating in the congestive heart failure treatment devices market are Abbott Laboratories, Medtronic plc, Baxter International Inc., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Charles River Laboratories International Inc., W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Biotronik SE & Co. KG, CryoLife Inc., HeartWare International Inc., Direct Flow Medical Inc., Berlin Heart GmbH, CVRx Inc., Micro Interventional Devices Inc., Jarvik Heart Inc, CardioKinetix Inc, Xeltis AG, Ancora Heart Inc, ReliantHeart Inc.

North America was the largest region in the congestive heart failure treatment devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the congestive heart failure treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The congestive heart failure treatment device market consists of sales of external defibrillators, total artificial hearts (TAHs), implantable cardioverter defibrillators, and intra-aortic balloon pumps (IABPs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congestive Heart Failure Treatment Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congestive heart failure treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congestive heart failure treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congestive heart failure treatment devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Cardiac Pacemaker; Implantable Cardioverter Defibrillators (ICDs); Cardiac Resynchronization Therapy Devices (CRT); Counter Pulsation Devices; Ventricular Assist Devices (VADs)
  • 2) By Application: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)
  • 3) By End-User: Hospitals And Clinic; Specialized Cardiovascular Disease Treatment Centers; Ambulatory Surgery Centers
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Baxter International Inc.; Boston Scientific Corporation; Terumo Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congestive Heart Failure Treatment Devices Market Characteristics

3. Congestive Heart Failure Treatment Devices Market Trends And Strategies

4. Congestive Heart Failure Treatment Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Congestive Heart Failure Treatment Devices Market Size and Growth

  • 5.1. Global Congestive Heart Failure Treatment Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Congestive Heart Failure Treatment Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Congestive Heart Failure Treatment Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Congestive Heart Failure Treatment Devices Market Segmentation

  • 6.1. Global Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiac Pacemaker
  • Implantable Cardioverter Defibrillators (ICDs)
  • Cardiac Resynchronization Therapy Devices (CRT)
  • Counter Pulsation Devices
  • Ventricular Assist Devices (VADs)
  • 6.2. Global Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BIVAD)
  • 6.3. Global Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinic
  • Specialized Cardiovascular Disease Treatment Centers
  • Ambulatory Surgery Centers

7. Congestive Heart Failure Treatment Devices Market Regional And Country Analysis

  • 7.1. Global Congestive Heart Failure Treatment Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Congestive Heart Failure Treatment Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Congestive Heart Failure Treatment Devices Market

  • 8.1. Asia-Pacific Congestive Heart Failure Treatment Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Congestive Heart Failure Treatment Devices Market

  • 9.1. China Congestive Heart Failure Treatment Devices Market Overview
  • 9.2. China Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Congestive Heart Failure Treatment Devices Market

  • 10.1. India Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Congestive Heart Failure Treatment Devices Market

  • 11.1. Japan Congestive Heart Failure Treatment Devices Market Overview
  • 11.2. Japan Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Congestive Heart Failure Treatment Devices Market

  • 12.1. Australia Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Congestive Heart Failure Treatment Devices Market

  • 13.1. Indonesia Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Congestive Heart Failure Treatment Devices Market

  • 14.1. South Korea Congestive Heart Failure Treatment Devices Market Overview
  • 14.2. South Korea Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Congestive Heart Failure Treatment Devices Market

  • 15.1. Western Europe Congestive Heart Failure Treatment Devices Market Overview
  • 15.2. Western Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Congestive Heart Failure Treatment Devices Market

  • 16.1. UK Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Congestive Heart Failure Treatment Devices Market

  • 17.1. Germany Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Congestive Heart Failure Treatment Devices Market

  • 18.1. France Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Congestive Heart Failure Treatment Devices Market

  • 19.1. Italy Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Congestive Heart Failure Treatment Devices Market

  • 20.1. Spain Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Congestive Heart Failure Treatment Devices Market

  • 21.1. Eastern Europe Congestive Heart Failure Treatment Devices Market Overview
  • 21.2. Eastern Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Congestive Heart Failure Treatment Devices Market

  • 22.1. Russia Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Congestive Heart Failure Treatment Devices Market

  • 23.1. North America Congestive Heart Failure Treatment Devices Market Overview
  • 23.2. North America Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Congestive Heart Failure Treatment Devices Market

  • 24.1. USA Congestive Heart Failure Treatment Devices Market Overview
  • 24.2. USA Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Congestive Heart Failure Treatment Devices Market

  • 25.1. Canada Congestive Heart Failure Treatment Devices Market Overview
  • 25.2. Canada Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Congestive Heart Failure Treatment Devices Market

  • 26.1. South America Congestive Heart Failure Treatment Devices Market Overview
  • 26.2. South America Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Congestive Heart Failure Treatment Devices Market

  • 27.1. Brazil Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Congestive Heart Failure Treatment Devices Market

  • 28.1. Middle East Congestive Heart Failure Treatment Devices Market Overview
  • 28.2. Middle East Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Congestive Heart Failure Treatment Devices Market

  • 29.1. Africa Congestive Heart Failure Treatment Devices Market Overview
  • 29.2. Africa Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Congestive Heart Failure Treatment Devices Market Competitive Landscape And Company Profiles

  • 30.1. Congestive Heart Failure Treatment Devices Market Competitive Landscape
  • 30.2. Congestive Heart Failure Treatment Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Baxter International Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Boston Scientific Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Terumo Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Congestive Heart Failure Treatment Devices Market Other Major And Innovative Companies

  • 31.1. Edwards Lifesciences Corporation
  • 31.2. Charles River Laboratories International Inc.
  • 31.3. W. L. Gore & Associates Inc.
  • 31.4. Bracco Group
  • 31.5. LivaNova PLC
  • 31.6. Meril Life Sciences Pvt. Ltd.
  • 31.7. Biotronik SE & Co. KG
  • 31.8. CryoLife Inc.
  • 31.9. HeartWare International Inc.
  • 31.10. Direct Flow Medical Inc.
  • 31.11. Berlin Heart GmbH
  • 31.12. CVRx Inc.
  • 31.13. Micro Interventional Devices Inc.
  • 31.14. Jarvik Heart Inc
  • 31.15. CardioKinetix Inc

32. Global Congestive Heart Failure Treatment Devices Market Competitive Benchmarking

33. Global Congestive Heart Failure Treatment Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Congestive Heart Failure Treatment Devices Market

35. Congestive Heart Failure Treatment Devices Market Future Outlook and Potential Analysis

  • 35.1 Congestive Heart Failure Treatment Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Congestive Heart Failure Treatment Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Congestive Heart Failure Treatment Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer